Related Experiment Video
Updated: Jan 9, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Large-Scale Study Comparing Analytical and Diagnostic Quality of Three HPV Self-Sampling Devices for At-Home Cervical
Alexander Arum1, Emilie Korsgaard Andreasen1, Helle Pedersen1
1Department of Pathology, afs. 134, AHH-Hvidovre Hospital, Copenhagen University Hospital, Hvidovre, Denmark.
Cervical cancer screening access is crucial. This study found three self-sampling devices yielded similar sample quality and HPV detection rates, suggesting factors beyond sample quality can guide device selection.
Area of Science:
- Gynecology
- Public Health
- Molecular Diagnostics
Background:
- Cervical cancer elimination necessitates widespread screening participation.
- Self-sampling devices offer improved accessibility but require validation for sample quality.
- Independent validation of self-sampling devices is limited.
Purpose of the Study:
- To compare the sample quality and HPV detection rates of three distinct self-sampling devices.
- To evaluate the analytical and diagnostic performance of HPV testing using samples from these devices.
- To inform the selection of self-sampling devices for cervical cancer screening programs.
Main Methods:
- A comparative study involving 1677 women in Denmark undergoing self-sampling.
- Participants received kits with combinations of three devices: Evalyn, FLOQSwab, and SensiGrip.
- Samples were analyzed for oncogenic HPV types using the BD Onclarity HPV assay.
Main Results:
- Sample quality was comparable across all three self-sampling devices, irrespective of participant age.
- The prevalence of oncogenic HPV types was 13.9% (232 women).
- High pairwise concordance (93.5%-95%) was observed between devices, indicating similar HPV detection performance.
Conclusions:
- Sample quality does not appear to be a deciding factor when choosing between Evalyn, FLOQSwab, and SensiGrip devices.
- The selection of self-sampling devices can prioritize other considerations like cost, user preference, and device ergonomics.
- These findings support the reliable use of various self-sampling technologies for HPV-based cervical cancer screening.
More Related Videos
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014